🚀 VC round data is live in beta, check it out!
Scope Fluidics Overview
About Scope Fluidics
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
Founded
2010
HQ
Employees
35
Website
Financials (LTM)
EV
$80M
Scope Fluidics Financials
Scope Fluidics reported last 12-month revenue of $555K and negative EBITDA of ($14M).
In the same LTM period, Scope Fluidics generated ($14M) in EBITDA losses and $20M in net income.
Revenue (LTM)
Scope Fluidics P&L
In the most recent fiscal year, Scope Fluidics reported revenue of $196K and EBITDA of ($12M).
Scope Fluidics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $555K | XXX | $196K | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($1M) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (517%) | XXX | XXX | XXX |
| EBITDA | ($14M) | XXX | ($12M) | XXX | XXX | XXX |
| EBITDA Margin | (2580%) | XXX | (5957%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (6724%) | XXX | XXX | XXX |
| Net Profit | $20M | XXX | ($12M) | XXX | XXX | XXX |
| Net Margin | 3648% | XXX | (6157%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Scope Fluidics Stock Performance
Scope Fluidics has current market cap of $124M, and enterprise value of $80M.
Market Cap Evolution
Scope Fluidics' stock price is $38.99.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $80M | $124M | 0.1% | XXX | XXX | XXX | $-3.81 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialScope Fluidics Valuation Multiples
Scope Fluidics trades at 144.9x EV/Revenue multiple, and (5.6x) EV/EBITDA.
EV / Revenue (LTM)
Scope Fluidics Financial Valuation Multiples
As of April 19, 2026, Scope Fluidics has market cap of $124M and EV of $80M.
Equity research analysts estimate Scope Fluidics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Scope Fluidics has a P/E ratio of 6.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $124M | XXX | $124M | XXX | XXX | XXX |
| EV (current) | $80M | XXX | $80M | XXX | XXX | XXX |
| EV/Revenue | 144.9x | XXX | 410.7x | XXX | XXX | XXX |
| EV/EBITDA | (5.6x) | XXX | (6.9x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (6.1x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (79.4x) | XXX | XXX | XXX |
| P/E | 6.1x | XXX | (10.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Scope Fluidics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Scope Fluidics Margins & Growth Rates
Scope Fluidics' revenue in the last 12 month grew by 152%.
Scope Fluidics' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
Scope Fluidics' rule of 40 is 3453% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Scope Fluidics' rule of X is 10837% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Scope Fluidics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 152% | XXX | 614% | XXX | XXX | XXX |
| EBITDA Margin | (2580%) | XXX | (5957%) | XXX | XXX | XXX |
| EBITDA Growth | 44% | XXX | 76% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 3453% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 10837% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 6207% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Scope Fluidics Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
Valuation data powered by FactSet, Inc.
Scope Fluidics M&A Activity
Scope Fluidics acquired XXX companies to date.
Last acquisition by Scope Fluidics was on XXXXXXXX, XXXXX. Scope Fluidics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Scope Fluidics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialScope Fluidics Investment Activity
Scope Fluidics invested in XXX companies to date.
Scope Fluidics made its latest investment on XXXXXXXX, XXXXX. Scope Fluidics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Scope Fluidics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Scope Fluidics
| When was Scope Fluidics founded? | Scope Fluidics was founded in 2010. |
| Where is Scope Fluidics headquartered? | Scope Fluidics is headquartered in Poland. |
| How many employees does Scope Fluidics have? | As of today, Scope Fluidics has over 35 employees. |
| Is Scope Fluidics publicly listed? | Yes, Scope Fluidics is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Scope Fluidics? | Scope Fluidics trades under SCP ticker. |
| When did Scope Fluidics go public? | Scope Fluidics went public in 2017. |
| Who are competitors of Scope Fluidics? | Scope Fluidics main competitors are Hyperfine, Fonar, MDxHealth, Curasight. |
| What is the current market cap of Scope Fluidics? | Scope Fluidics' current market cap is $124M. |
| What is the current revenue of Scope Fluidics? | Scope Fluidics' last 12 months revenue is $555K. |
| What is the current revenue growth of Scope Fluidics? | Scope Fluidics revenue growth (NTM/LTM) is 152%. |
| What is the current EV/Revenue multiple of Scope Fluidics? | Current revenue multiple of Scope Fluidics is 144.9x. |
| Is Scope Fluidics profitable? | No, Scope Fluidics is not profitable. |
| What is the current EBITDA of Scope Fluidics? | Scope Fluidics has negative EBITDA and is not profitable. |
| What is Scope Fluidics' EBITDA margin? | Scope Fluidics' last 12 months EBITDA margin is (2580%). |
| What is the current EV/EBITDA multiple of Scope Fluidics? | Current EBITDA multiple of Scope Fluidics is (5.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.